ArticleCancer medicine2023

Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project.

Giacomo Coltro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.